This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
ME/CFS Science
mecfsscience.org
did:plc:ith7dzcppw7ru2enoauywkld
1) A new randomized trial in Long Covid patients tested Temelimab, a drug that targets a potentially pathogenic protein (HERV-W ENV) from endogenous retroviruses.
Unfortunately, the results are pretty clear: Temelimab had no beneficial effect.
2026-07-14T07:52:16.471Z